TREX1 targeting therapy (Qubit Pharmaceuticals)

N/A

Report date: 2025/04/17 16:23:41
NME

Base Information

Drug NameTREX1 targeting therapy (Qubit Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThree Prime Repair Exonuclease 1 inhibitors
TargetsThree Prime Repair Exonuclease 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQubit Pharmaceuticals sas
China Registration ClassN/A

Develop Information

Active CompaniesQubit Pharmaceuticals sas
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A